← Back to Clinical Trials
Recruiting NCT05391932

NCT05391932 Making INformed Decisions in Gaze and Postural Stability: A Pilot Feasibility Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05391932
Status Recruiting
Phase
Sponsor University of Montana
Condition Vestibular Hypofunction
Study Type INTERVENTIONAL
Enrollment 36 participants
Start Date 2022-05-11
Primary Completion 2026-09-30

Eligibility & Interventions

Sex All sexes
Min Age 40 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
MINDGAPS

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 36 participants in total. It began in 2022-05-11 with a primary completion date of 2026-09-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The proposed research is relevant to vestibular science and the general public because age-related vestibular hypofunction is a major contributor to poor balance, falls, and other adverse health outcomes. In this investigation the investigators will: 1) assess the preliminary efficacy of a novel intervention system for improving vestibular function and dizziness in community-dwelling older adults, 2) assess the safety and feasibility of the this system, and 3) assess the acceptability and implementation potential of this system, prior to a large-scale, R01-level investigation.

Eligibility Criteria

Inclusion Criteria: * Reports issues with dizziness or imbalance * Ability to stand independently * Presence of peripheral vestibular hypofunction as indicated by examination with video nystagmography, video head impulse testing, or dynamic visual acuity testing. Exclusion Criteria: * cervical spine disorders * vertebral or carotid artery dissection * blindness * peripheral or central oculomotor palsy * centrally mediated vestibular dysfunction

Contact & Investigator

Central Contact

Brian J Loyd, PhD

✉ Brian.loyd@umontana.edu

📞 406-243-4015

Frequently Asked Questions

Who can join the NCT05391932 clinical trial?

This trial is open to participants of all sexes, aged 40 Years or older, studying Vestibular Hypofunction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05391932 currently recruiting?

Yes, NCT05391932 is actively recruiting participants. Contact the research team at Brian.loyd@umontana.edu for enrollment information.

Where is the NCT05391932 trial being conducted?

This trial is being conducted at Missoula, United States.

Who is sponsoring the NCT05391932 clinical trial?

NCT05391932 is sponsored by University of Montana. The trial plans to enroll 36 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology